Abstracts and Articles

Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China.

Liang Yebei (Y);Yu Rong (R);Ye Xiaoqi (X);Yang Lu (L);Jiang Fusong (F);Feng Liang (L);Zhong Lichang (L);Dong Keqing (K);Wei Li (L);Bao Yuqian (Y);Hou Xuhong (X);Jia Weiping (W)

Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson's disease in China: A retrospective study.

Wang Meixia (M);Wang Fei (F);Tao Zhuang (Z);Yang Wenming (W)

Association of metabolic dysfunction-associated fatty liver disease with coronary CT angiography-derived plaque characteristics and cardiovascular events.

Wang Jin-Jin (JJ);Huang Xiao-Lan (XL);Guo Yi (Y);Tao Xin-Wei (XW);Zeng Meng-Su (MS);Ji Yi-Ding (YD);Zhou Jian-Jun (JJ);Yu Meng-Meng (MM)

The Association Between Physical Activity, Sedentary Time, and Sleep with Risk of Hepatocellular Carcinoma in Patients with Cirrhosis.

Ma Samuel (S);Alsabawi Yossef (Y);Kanwal Fasiha (F);Duong Hao (H);Elserag Laith (L);Singal Amit G (AG);Rich Nicole E (NE);Khaderi Saira (S);Asrani Sumeet K (SK);El-Serag Hashem B (HB);Thrift Aaron P (AP)

Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.

Bansal Meena B (MB);Patton Heather (H);Morgan Timothy R (TR);Carr Rotonya M (RM);Dranoff Jonathan (J);Allen Alina M (AM)

Endocan in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.

Behnoush Amir Hossein (AH);Khalaji Amirmohammad (A);Karimi Elaheh (E);Shokri Varniab Zahra (Z);Kanagala Sai Gautham (SG);Yaghoobi Alireza (A);Mercantepe Filiz (F);Klisic Aleksandra (A)

Effect of vitamin E on cardiometabolic factors in pediatric Metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review with meta-analysis.

Pam Pedram (P);Musazadeh Vali (V);Mahmoudinezhad Mahsa (M);Panahiyan Pegah (P);Mansoori Mohammad Amin (MA);Zarrin Rasoul (R);Faghfouri Amir Hossein (AH)

Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study.

Dimitropoulou Nefeli M (NM);Beran Magdalena (M);Eussen Simone J P M (SJPM);Dingena Cassy F (CF);Dagnelie Pieter C (PC);van der Kallen Carla J H (CJH);Koster Annemarie (A);van Greevenbroek Marleen M J (MMJ);Brouwers Martijn C G J (MCGJ);Schram Miranda T (MT);de Galan Bastiaan E (BE)

Quantitative assessment of hepatic steatosis by ultrasound-guided attenuation parameter in patients with impaired glucose tolerance.

Gao Ruixia (R);Han Jiahao (J);Song Danlei (D);Wang Pingping (P);Chen Huihui (H);Shen Huiming (H);Li Jia (J)

Effects of long working hours on metabolic dysfunction-associated steatotic liver disease, with and without increased alcohol intake, in healthy workers: A 10-year cohort study.

Lee Yesung (Y);Lee Woncheol (W)

The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

So Jae Eun (JE);Jeong Jaehong (J);Hong Jung Pyo (JP);Kim Dong Yun (DY);Lee Jae Seung (JS);Kim Mi Na (MN);Kim Beom Kyung (BK);Park Jun Yong (JY);Kim Do Young (DY);Lee Hye Won (HW);Kim Seung Up (SU)

The stronger predictive role of early life exposures versus current lifestyle behaviors on the development of childhood severe obesity and metabolic dysfunction.

Tang MengYan (M);Li Yuan (Y);Liu XiaoMei (X);Li Ping (P)

Postoperative supplementation with high-titer pancreatic enzymes and zinc acetate dihydrate could reduce the risk of liver fat deposition, especially in patients with severe remnant pancreatic atrophy after pancreaticoduodenectomy: a retrospective study.

Matsukuma Satoshi (S);Kinjo Naoki (N);Suzuki Atomu (A);Nishio Yusuke (Y);Yamamoto Naohiro (N);Taura Yohei (Y);Tokuno Kazuhisa (K);Sakano Hisashi (H);Kawaoka Toru (T);Akiyama Norio (N);Yamamoto Shigeru (S)

The effectiveness of transcranial electrical stimulation in individuals with specific learning disorder (SLD): systematic review and transfer analysis.

Nejati Vahid (V);Ghafuri Fateme (F);Hosseini Katayoon (K);Behroozmand Roozbeh (R)

Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes.

Lu Lusi (L);Gao Chenlu (C);Wu Nan (N);He Sunyue (S);Liu Yiming (Y);Zhang Nan (N);Zhou Jiaqiang (J)

Remnant cholesterol, low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: a cohort study.

Zhou Di (D);Zhou Mengge (M);Chen Shuohua (S);Yang Chenlu (C);Wang Yanhong (Y);Zhou Yang (Y);Wu Shutong (S);Wu Shouling (S);Wang Li (L)

Clinical and laboratory characteristics of novel diabetes subgroups: A systematic review and meta-analysis.

Ao Na (N);Li Jia (J);Wang Qian (Q);Du Jian (J);Jin Shi (S);Yang Jing (J)

Intermittent fasting and liver disease: Insights from the Ramadan model.

Khalifa Rofida (R);Al-Naamani Khalid (K);Elbadry Mohamed (M);Alswat Khalid (K);El-Kassas Mohamed (M)